Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Nvo crawled date : 2021 - 08 - 16 save search
Major Depressive Disorder Therapeutic Market Size Expected to Witness Growth at a CAGR of 8.91% for the Study Period 2018-2030 | DelveInsight
Published: 2021-08-16 (Crawled : 18:00) - prnewswire.com
NVO | News | $128.31 2.44% 2.2M
|
Health Technology
|
| O: 0.63%
H: 0.65%
C: 0.64%
JNJ | News | $150.09 0.65% 3.9M
|
Health Technology
|
| O: 0.86%
H: 0.76%
C: 0.73%
TNXP | $0.1568 0.9% 900K
|
Health Technology
|
| O: 0.01%
H: 2.91%
C: 0.41%
SNY | News | $47.5 0.74% 450K
|
Health Technology
|
| O: 0.17%
H: 0.62%
C: 0.48%
growth depression major depressive disorder
Novo Nordisk A/S – Share repurchase programme
Published: 2021-08-16 (Crawled : 13:00) - globenewswire.com
NVO | News | $128.31 2.44% 2.2M
|
Health Technology
|
| O: 0.63%
H: 0.65%
C: 0.64%
s
Gainers vs Losers
| 87% | 13% |
Top 10 Gainers
MTTR | News M | $4.64 166.67% 18M
|
AGBA | $2.61 108.8% 41M
|
Finance
CZOO | $9.32 86.77% 18M
|
EDBL | News | $6.7 78.19% 1.7M
|
OPRT | News | $3.37 49.78% 8.9M
|
Finance
MTC | $2.14 37.18% 4.9M
|
Technology Services
VNRX | $0.8 33.33% 2.9M
|
Health Technology
MLEC | $1.79 27.86% 2.6M
|
n/a
PALI | $6.29 27.59% 22M
|
Manufacturing
MCRB | $0.7902 26.51% 6.9M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.